CTOs on the Move

Linda Lopez De Roman

www.inspanamericano.com

 
Linda Lopez De Roman is a San Antonio, TX-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Miller and Gaines

Miller and Gaines is a Atlanta, GA-based company in the Business Services sector.

PSB Marketing

PSB Marketing is a Lake Forest, CA-based company in the Business Services sector.

NetVenture Holdings

NetVenture Holdings is a Washington, DC-based company in the Business Services sector.

Annodyne Interactive

Annodyne, Inc. is a professional services company providing Internet business strategy, creative and technical execution for a diverse clientele. The company is centered on their vision of The New Marketing Economy, and developing Internet-centric

Mural Oncology

We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA)